126 related articles for article (PubMed ID: 35972404)
1. Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact.
Graham M; Graves D; Cooley L; Elvy J; Kelley P; Maley M; Porter M; Robson J; Turnidge J
J Antimicrob Chemother; 2022 Oct; 77(11):3064-3068. PubMed ID: 35972404
[TBL] [Abstract][Full Text] [Related]
2. RCPAQAP audit of antimicrobial reporting in Australian and New Zealand laboratories: opportunities for laboratory contribution to antimicrobial stewardship.
Graham M; Walker DA; Haremza E; Morris AJ
J Antimicrob Chemother; 2019 Jan; 74(1):251-255. PubMed ID: 30295792
[TBL] [Abstract][Full Text] [Related]
3. ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.
Farshid G; Bilous M; Morey A; Fox S; Lakhani S; Loi S; Bell R; Spillane A
Pathology; 2019 Jun; 51(4):345-348. PubMed ID: 31076089
[TBL] [Abstract][Full Text] [Related]
4. Reporting unit size and measurement uncertainty: current Australian practice in clinical chemistry and haematology.
Hawkins RC; Badrick T
Pathology; 2015 Aug; 47(5):462-5. PubMed ID: 26126036
[TBL] [Abstract][Full Text] [Related]
5. Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program.
Francis GD; Dimech M; Giles L; Hopkins A
J Clin Pathol; 2007 Nov; 60(11):1277-83. PubMed ID: 17259294
[TBL] [Abstract][Full Text] [Related]
6. Missing parameters in malignant polyp histology reports: can appropriate decisions be made?
Zammit AP; Brown I; Hooper JD; Clark DA; Riddell AD
Pathology; 2023 Feb; 55(1):58-63. PubMed ID: 36109194
[TBL] [Abstract][Full Text] [Related]
7. Highlighted issues from the second edition RCPA Endometrial Cancer Structured Reporting Protocol.
Ireland-Jenkin K; Selinger C; Newman M
Pathology; 2020 Apr; 52(3):293-296. PubMed ID: 32113674
[TBL] [Abstract][Full Text] [Related]
8. Laboratory reporting of urine protein and albumin.
Jones GR
Clin Biochem Rev; 2011 May; 32(2):103-7. PubMed ID: 21611084
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial stewardship activities: a survey of Queensland hospitals.
Avent ML; Hall L; Davis L; Allen M; Roberts JA; Unwin S; McIntosh KA; Thursky K; Buising K; Paterson DL
Aust Health Rev; 2014 Nov; 38(5):557-63. PubMed ID: 25376911
[TBL] [Abstract][Full Text] [Related]
10. Reporting of estimated glomerular filtration rate (eGFR) in New Zealand--what are the clinical laboratories doing?
Saleem M; Florkowski C;
N Z Med J; 2006 Dec; 119(1246):U2337. PubMed ID: 17151711
[TBL] [Abstract][Full Text] [Related]
11. Consensus guidelines on anti-cardiolipin antibody testing and reporting.
Wong RC; Gillis D; Adelstein S; Baumgart K; Favaloro EJ; Hendle MJ; Homes P; Pollock W; Smith S; Steele RH; Sturgess A; Wilson RJ
Pathology; 2004 Feb; 36(1):63-8. PubMed ID: 14757559
[TBL] [Abstract][Full Text] [Related]
12. An evidence- and risk-based approach to a harmonized laboratory alert list in Australia and New Zealand.
Campbell CA; Lam Q; Horvath AR
Clin Chem Lab Med; 2018 Dec; 57(1):89-94. PubMed ID: 29672264
[TBL] [Abstract][Full Text] [Related]
13. EQA from an Australian perspective.
Bais R
Clin Biochem Rev; 2007 Nov; 28(4):175-8. PubMed ID: 18392130
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic 'errors' in anatomical pathology: relevance to Australian laboratories.
Leong AS; Braye S; Bhagwandeen B
Pathology; 2006 Dec; 38(6):490-7. PubMed ID: 17393975
[TBL] [Abstract][Full Text] [Related]
15. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
[TBL] [Abstract][Full Text] [Related]
16. Richard Charles Nairn, Foundation Professor of Pathology and Immunology at Monash University.
Muller HK
Pathology; 1999 Aug; 31(3):295-9. PubMed ID: 10503281
[TBL] [Abstract][Full Text] [Related]
17. Over-reporting significant figures--a significant problem?
Hawkins RC; Badrick T; Hickman PE
Clin Chim Acta; 2007 Jan; 375(1-2):158-61. PubMed ID: 16839534
[TBL] [Abstract][Full Text] [Related]
18. The frequency and potential clinical impact of non-analytical errors in the RCPA Microbiology QAP 1987-2008.
Morris AJ; Haremza E; Walker DA
Pathology; 2011 Jun; 43(4):346-9. PubMed ID: 21519289
[TBL] [Abstract][Full Text] [Related]
19. Blood culture quality assurance: findings from a RCPAQAP Key Incident Monitoring and Management Systems (KIMMS) audit of blood culture performance.
Elvy J; Haremza E; Morris AJ; Whiley M; Gay S
Pathology; 2023 Oct; 55(6):850-854. PubMed ID: 37400348
[TBL] [Abstract][Full Text] [Related]
20. Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays.
Krummenacher M; Lee FJ; Wienholt L; Hissaria P
Pathology; 2021 Dec; 53(7):883-888. PubMed ID: 33994175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
